JP2010524849A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524849A5 JP2010524849A5 JP2010501126A JP2010501126A JP2010524849A5 JP 2010524849 A5 JP2010524849 A5 JP 2010524849A5 JP 2010501126 A JP2010501126 A JP 2010501126A JP 2010501126 A JP2010501126 A JP 2010501126A JP 2010524849 A5 JP2010524849 A5 JP 2010524849A5
- Authority
- JP
- Japan
- Prior art keywords
- rap
- cyclic
- mutation
- peptide
- rap peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91923807P | 2007-03-21 | 2007-03-21 | |
| PCT/US2008/057863 WO2008116171A1 (en) | 2007-03-21 | 2008-03-21 | Cyclic receptor-associated protein (rap) peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010524849A JP2010524849A (ja) | 2010-07-22 |
| JP2010524849A5 true JP2010524849A5 (enExample) | 2012-04-19 |
Family
ID=39591450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010501126A Pending JP2010524849A (ja) | 2007-03-21 | 2008-03-21 | 環状受容体関連蛋白ペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8440629B2 (enExample) |
| EP (1) | EP2132224B1 (enExample) |
| JP (1) | JP2010524849A (enExample) |
| KR (2) | KR101801454B1 (enExample) |
| CN (1) | CN101861334A (enExample) |
| AT (1) | ATE539089T1 (enExample) |
| BR (1) | BRPI0809234A2 (enExample) |
| CA (1) | CA2681522A1 (enExample) |
| MX (1) | MX2009010148A (enExample) |
| WO (1) | WO2008116171A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1747747B (zh) | 2003-01-06 | 2012-09-05 | 安吉奥开米公司 | 作为穿过血脑屏障的载体的抑酶肽及类似物 |
| US9365634B2 (en) | 2007-05-29 | 2016-06-14 | Angiochem Inc. | Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues |
| RU2518240C2 (ru) | 2008-04-18 | 2014-06-10 | Ангиочем Инк. | Композиция, на основе гидрофобных агентов и способ ее получения(варианты) |
| WO2010027802A2 (en) * | 2008-08-25 | 2010-03-11 | New York University | Methods for treating diabetic wounds |
| RU2531591C2 (ru) | 2008-10-15 | 2014-10-20 | Ангиокем Инк. | Конъюгаты этопозида и доксорубицина для доставки лекарственных средств |
| US8921314B2 (en) | 2008-10-15 | 2014-12-30 | Angiochem, Inc. | Conjugates of GLP-1 agonists and uses thereof |
| MX2011005963A (es) | 2008-12-05 | 2011-09-01 | Angiochem Inc | Conjugados de neurotensina o analogos de neurotensina y sus usos. |
| CN102300987A (zh) | 2008-12-17 | 2011-12-28 | 安吉奥开米公司 | 膜型-1基质金属蛋白抑制剂及其用途 |
| WO2010117957A2 (en) * | 2009-04-06 | 2010-10-14 | Mayo Foundation For Medical Education And Research | Methods and materials for delivering molecules |
| AU2010239069B2 (en) | 2009-04-20 | 2015-05-14 | Angiochem Inc | Treatment of ovarian cancer using an anticancer agent conjugated to an Angiopep-2 analog |
| MX2012000016A (es) | 2009-07-02 | 2012-03-26 | Angiochem Inc | Conjugados de peptidos multimericos y sus usos. |
| AU2011210756B2 (en) * | 2010-01-28 | 2016-11-03 | Horizon Orphan Llc | Method For Treating Liver Disorders With Receptor Associated Protein (RAP) Peptide-Fucosidase Inhibitor Conjugates |
| US9254310B2 (en) | 2010-06-17 | 2016-02-09 | New York University | Therapeutic and cosmetic uses and applications of calreticulin |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| GB201220474D0 (en) * | 2012-11-14 | 2012-12-26 | Sagetis Biotech Sl | Polypeptides |
| EP3038657A2 (en) | 2013-08-28 | 2016-07-06 | Bioasis Technologies Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| EP3259280A4 (en) * | 2015-02-20 | 2018-07-18 | The Regents of The University of California | Methods and compositions for treating glaucoma |
| US10980892B2 (en) | 2015-06-15 | 2021-04-20 | Angiochem Inc. | Methods for the treatment of leptomeningeal carcinomatosis |
| CN109422801B (zh) * | 2017-08-31 | 2022-07-08 | 复旦大学 | 多功能靶向多肽rap及其在制备肿瘤靶向递送系统中的用途 |
| WO2019108806A1 (en) * | 2017-11-29 | 2019-06-06 | Board Of Regents Of The University Of Texas System | Compositions and methods for cancer therapy |
| US12305171B2 (en) | 2018-12-27 | 2025-05-20 | Bioaffinity Technologies, Inc. | Compositions and methods for treating cancer |
| WO2020139866A2 (en) * | 2018-12-27 | 2020-07-02 | Bioaffinity Technologies, Inc. | Compositions and methods for treating cancer |
| US11572394B2 (en) * | 2020-02-16 | 2023-02-07 | Pasteur Institute Of Iran | Peptides for targeting LRP6-overexpressed cells |
| EP3954393A1 (en) | 2020-08-13 | 2022-02-16 | Bioasis Technologies Inc. | Combination therapies for delivery across the blood brain barrier |
| CN116286380B (zh) * | 2021-12-21 | 2026-01-09 | 暨南大学 | 环五肽类化合物及其在α-糖苷酶抑制剂类降糖药物或预防保健品中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394448A (en) * | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
| IT1122765B (it) * | 1978-11-06 | 1986-04-23 | Srm Hydromekanik Ab | Frizione a dischi multipli |
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| US5186941A (en) * | 1983-05-06 | 1993-02-16 | Vestar, Inc. | Vesicle formulation for the controlled release of therapeutic agents |
| US6048729A (en) * | 1987-05-01 | 2000-04-11 | Transkaryotic Therapies, Inc. | In vivo protein production and delivery system for gene therapy |
| US6063630A (en) * | 1991-11-05 | 2000-05-16 | Transkaryotic Therapies, Inc. | Targeted introduction of DNA into primary or secondary cells and their use for gene therapy |
| US6238908B1 (en) * | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
| US6069167A (en) * | 1996-01-16 | 2000-05-30 | University Technology Corporation | Use of antioxidant agents to treat cholestatic liver disease |
| TW492882B (en) * | 1997-11-28 | 2002-07-01 | Caleb Pharmaceuticals Inc | Cholinergic antagonist plaster composition |
| US6585971B1 (en) * | 1999-11-12 | 2003-07-01 | Harbor-Ucla Research And Education Institute | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof |
| US6569661B1 (en) * | 1999-11-12 | 2003-05-27 | Biomarin Pharmaceutical Inc. | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| US6426208B1 (en) * | 1999-11-12 | 2002-07-30 | Harbor-Ucla Research And Education Institute | Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| US6261595B1 (en) * | 2000-02-29 | 2001-07-17 | Zars, Inc. | Transdermal drug patch with attached pocket for controlled heating device |
| US6596762B2 (en) * | 2001-05-17 | 2003-07-22 | The Regents Of The University Of Colorado | Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis |
| US7485314B2 (en) * | 2002-05-06 | 2009-02-03 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Induction of antigen specific immunologic tolerance |
| AU2004253471B2 (en) * | 2003-06-20 | 2010-05-13 | Raptor Pharmaceutical Inc. | Delivery of therapeutic compounds to the brain and other tissues |
| WO2006138343A2 (en) | 2005-06-14 | 2006-12-28 | Raptor Pharmaceutical Inc. | Compositions comprising receptor - associated protein (rap) variants specific for lrp2 and uses thereof |
| KR20090071598A (ko) * | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
-
2008
- 2008-03-21 WO PCT/US2008/057863 patent/WO2008116171A1/en not_active Ceased
- 2008-03-21 CA CA002681522A patent/CA2681522A1/en not_active Abandoned
- 2008-03-21 KR KR1020157020697A patent/KR101801454B1/ko not_active Expired - Fee Related
- 2008-03-21 BR BRPI0809234-6A patent/BRPI0809234A2/pt not_active Application Discontinuation
- 2008-03-21 AT AT08732675T patent/ATE539089T1/de active
- 2008-03-21 JP JP2010501126A patent/JP2010524849A/ja active Pending
- 2008-03-21 KR KR1020097022037A patent/KR20100015786A/ko not_active Ceased
- 2008-03-21 MX MX2009010148A patent/MX2009010148A/es active IP Right Grant
- 2008-03-21 EP EP08732675A patent/EP2132224B1/en not_active Not-in-force
- 2008-03-21 US US12/600,786 patent/US8440629B2/en not_active Expired - Fee Related
- 2008-03-21 CN CN200880016942A patent/CN101861334A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | D‐peptides as recognition molecules and therapeutic agents | |
| KR101617790B1 (ko) | 치료, 진단과 실험적 혼합물들의 운반을 위한 공학적으로 가변된 나노입자 및 치료용 관련 조성물 | |
| US7138105B2 (en) | Compositions for delivery of therapeutics and other materials, and methods of making and using the same | |
| IL321500A (en) | Pre-stabilized hmpv f proteins | |
| TWI886164B (zh) | 1價ccap生成物之製造方法 | |
| US20170007669A1 (en) | Peptide-mediated delivery of active agents across the blood-brain barrier | |
| JP7678654B2 (ja) | 複合体及びその使用 | |
| JP2009502135A5 (enExample) | ||
| US12465646B2 (en) | Linkers | |
| JP2017529059A5 (enExample) | ||
| JP7674031B2 (ja) | 細胞透過性ペプチド | |
| BRPI0620806A2 (pt) | peptìdeos úteis como peptìdeos de penetração de célula | |
| JP2010507391A (ja) | 組織傷害の修復におけるストロマ細胞由来因子１のプロテアーゼ耐性変異体 | |
| JP2015509097A5 (enExample) | ||
| AU2021202789A1 (en) | Cancer immunotherapeutic | |
| US20150252081A1 (en) | Methods and compositions for controlling assembly of viral proteins | |
| JP2003514852A (ja) | 炎症反応を阻害する細胞透過性ペプチドおよび使用方法 | |
| JP2009508494A5 (enExample) | ||
| US20200131231A1 (en) | Cell penetrating peptides | |
| JP2022118184A (ja) | コンジュゲートされたｃ１エステラーゼインヒビター及びその使用 | |
| JP2025166082A (ja) | 分子ガイドシステムペプチド及びその使用 | |
| US10072065B2 (en) | Peptide-mediated delivery of immunoglobulins across the blood-brain barrier | |
| JP7766489B2 (ja) | 免疫調節特性を有するペプチド | |
| US20230399378A1 (en) | Peptide-based delivery of agents | |
| WO2024042466A1 (en) | Brain penetrating peptides and methods of use thereof |